Well-considered genetic studies have since elucidated this biology, including the independently replicated findings that either ALDH1a1 or RXR genetic knockout leads to obesity resistance and that pharmacologic treatments with either WIN18446 or disulfiram similarly reverse obesity. The gene discussed is ALDH1A1; the disease is obesity disorder.